Publishing research using ab154131? Please let us know so that we can cite the reference in this datasheet.

ab154131 has been referenced in 5 publications.

  • Reyes-Soffer G  et al. Effects of PCSK9 Inhibition With Alirocumab on Lipoprotein Metabolism in Healthy Humans. Circulation 135:352-362 (2017). PubMed: 27986651
  • Millar JS  et al. Effects of CETP inhibition with anacetrapib on metabolism of VLDL-TG and plasma apolipoproteins C-II, C-III, and E. J Lipid Res 58:1214-1220 (2017). PubMed: 28314859
  • Luo M  et al. ApoCIII enrichment in HDL impairs HDL-mediated cholesterol efflux capacity. Sci Rep 7:2312 (2017). PubMed: 28539597
  • Lin Q  et al. Decreased expression of the APOA1-APOC3-APOA4 gene cluster is associated with risk of Alzheimer's disease. Drug Des Devel Ther 9:5421-31 (2015). ELISA . PubMed: 26491253
  • Xiong X  et al. The association of HDL-apoCIII with coronary heart disease and the effect of statin treatment on it. Lipids Health Dis 14:127 (2015). ELISA ; Human . PubMed: 26452348

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"

Sign up